5795, avenue De Gaspé, 3rd Floor, Room 208
Montreal, Quebec H2S 2X3

Phone: 514 274-1001
Fax: 514 723-0032
Email: info@ctssante.ca

Join us
  • Increase font size
  • Default font size
  • Decrease font size
  • default style
  • blue style
  • green style
  • red style
  • orange style
img
img
img
img
img
img

The MedTech Challenge 2013

Identify, Motivate and Guide the futur entrepreneurs in the medical technologies sector. Read more…

Read more

Match Perfect

Eligibility Companies should have some of the following characteristics but each company…

Read more

Top 10 Finance

Objectives Top 10 Finance aims to provide the 10 best medical companies…

Read more

Tech•Action

TECHACTION™ "Beyond traditional business consulting services: For the right business execution For…

Read more

Rental office space

Espace•Vie CTS 5795, De Gaspé Avenue, Montreal Rental Office Space / Business…

Read more

Medtech Club

Medtech•Clubs are thematic breakfast roundtables with Chief Executives and experts in the…

Read more

Nouvelles

Renowned medical device entrepreneur Steve Arless joins CTS Board.

Montreal (April 15, 2013) - The CTS Healthcare Board of Directors is pleased to welcome Mr. Steve Arless as a new member of the board.

Mr. Arless brings more than 35 years of extensive Canadian and international experience in the development, marketing and sales of medical devices to the CTS. He began his career with Smith & Nephew Inc., where he rose to serve as President of the Canadian operations. From their Mr. Arless notably served as President and Chief Executive Officer of CryoCath Technologies Inc from April 1996 to July 2006. In that time, he took the company from a start-up to a worldwide recognized leader in the field cardiac electrophysiology. CryoCath was ultimately acquired by Medtronic Inc in 2008.

After the great success of CryoCath, Mr. Arless has supported a number of local medical device companies including Cardianove; Resonant Medical, and Skeltex. Then starting in March 2009, he became CEO of CardioInsight up to April 2012. CardioInsight, a Cleveland-based company, has raised over $20 million in Series B and C financing rounds. Its technology is now recognized as the future of cardiac mapping systems.

M. Arless served on the Board of Directors of several Canadian medical devices companies. He also teaches, as Adjunct Professor, at the post-graduate level at Concordia University’s John Molson School of Business in Montreal, with a focus on Entrepreneurism and Corporate Governance. Mr. Arless’ most recent award, in October, 2005, was as Ernst and Young Entrepreneur of the Year in healthcare. Mr. Arless holds a B.Sc. degree in Chemistry from McGill University, and an MBA from Concordia University in Montreal.

« I am very pleased to welcome Mr. Arless to CTS board. His vision and experience in building early stage medical technology companies, and his commitment to the development of the medical technology sector in Canada and Quebec, will be a tremendous asset for CTS and its companies » said Mr. Frank Baylis, chairman of CTSs Healthcare board.

Mr. Arless joins the 9 board members, guiding CTSs Healthcare strategic goals that include:

  • Mr. Jacques Baril, President of the regional counsel at Caisses Desjardins East of Montréal;
  • Mr. Frank Baylis, President and CEO at Baylis Medical;
  • Mr. Yvan Beaudoin, president and CEO of Maetta Systems;
  • Mr. Stéphane Couture, Director, Product Management at TELUS Health Solutions;
  • Mr. Jean-Nicolas Delage, Associate at Fasken Martineau;
  • Mr. Tony Falco, president and CEO at Elekta Canada;
  • Ms. Danièle Lalande, Associate at Gascon & associés
  • Ms. Geneviève Lavertu, Director, Legal Affairs, Business Development and Clinical Research at Medtronic Canada;
  • Mr. Reginald Lavertu, Chair of CDEC Rosemont Petite Patrie board.

About the CTS

The CTS stimulates the momentum of the medical devices sector in Canada. Since its inauguration in September 2009, the CTS has provided companies in the medical device sector with a structured framework for success. The support provided includes a synergistic environment, mentoring, consulting services, and a network of partners able to assist companies in their development, sustainability and international exposure.

To this end, the CTS provide a series of services, physical facilities, a network of experts, and programs and services to Quebec and global enterprises.

2ème Édition du Défi Medtech 2012 Print
There are no translations available.

Montréal le 21 septembre 2012- Le Campus des Technologies de la Santé (CTS) et Mitacs, ont le plaisir d’annoncer que l’équipe pluridisciplinaire constituée de Messieurs : Roozbeh Safavieh de McGill University, Tohid Fatanat Didar, de McGill University, Babak Safavieh de INRS-EMT et Ehsan Derayati de Concordia University, sont les gagnants de la bourse Medtech Excellence 2012. Leur projet, Low cost microchip for Point of care high sensitive assays,a été sélectionné comme le projet gagnant par le jury composé de  Messieurs : Jean-Nicolas...

 
APPOINTMENT OF NEW BOARD MEMBERS FOR CTS HEALTHCARE Print
04652_nouveaux_membres_du_conseil 

From left to right: Tony Falco, Meriem Benmelouka, Yvan Beaudoin, Genevieve Lavertu,·Jean Nicolas Delage, Stephane Couture and Reginald Lavertu

CTS Healthcare Board of Directors is pleased to welcome five new members.

Joining the Board of Directors from the medical...

 

Temoignages